Endocrinology News and Research

Latest Endocrinology News and Research

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

30 May 2013

Adult stem cells combined with new drug could hold key to curing type 1 diabetes

Millions of people with type 1 diabetes depend on daily insulin injections to survive. They would die without the shots because their immune system attacks the very insulin-producing cells it was designed to protect. Now, a University of Missouri scientist has discovered that this attack causes more damage than scientists realized. The revelation is leading to a potential cure that combines adult stem cells with a promising new drug.

29 May 2013

First Edition: May 29, 2013

Today's early morning highlights from the major news organizations include a look at California's effort to expand health care and reports on the Supreme Court's announcement that stops Indiana from barring Planned Parenthood from Medicaid funding.

29 May 2013

Scientists discover new function of an enzyme that disposes of superfluous proteins

Cells have a sophisticated system to control and dispose of defective, superfluous proteins and thus to prevent damage to the body. Dr. Katrin Bagola and Professor Thomas Sommer of the Max Delbr-ck Center for Molecular Medicine Berlin-Buch as well as Professor Michael Glickman and Professor Aaron Ciechanover of Technion, the Technical University of Israel in Haifa, have now discovered a new function of an enzyme that is involved in this vital process.

29 May 2013

Offspring of long-lived parents less prone to cancer, study reveals

The offspring of parents who live to a ripe old age are more likely to live longer themselves, and less prone to cancer and other common diseases associated with ageing, a study has revealed.

29 May 2013

Harmless genetic variations may team up to increase risk of schizophrenia, find researchers

Using a novel method of analyzing genetic variations in families, researchers at Johns Hopkins have found that individually harmless genetic variations affecting related biochemical processes may team up to increase the risk of schizophrenia.

29 May 2013

New Smartphone app helps maintain accurate records to manage diabetes

Vital improvements can be made to patients diabetes control, by ensuring a recent blood glucose history is available to their Specialist Nurse. Traditionally patients have recorded their results in a paper logbook but now the new app from GlucoMen is a fantastic alternative using Smartphone technology to ensure a complete and accurate record.

28 May 2013

Synthetic compound derived from sea anemone toxin shows potential to treat obesity

Scientists at UC Irvine reported this week that a synthetic compound ShK-186, originally derived from a sea anemone toxin, has been found to enhance metabolic activity and shows potential as a treatment for obesity and insulin resistance.

28 May 2013

Omthera to be acquired by AstraZeneca

AstraZeneca today announced that it has entered into a definitive agreement to acquire Omthera Pharmaceuticals, a specialty pharmaceutical company based in Princeton, New Jersey, focused on the development and commercialization of new therapies for abnormal levels of lipids in the blood, referred to as dyslipidemia.

28 May 2013

New deal to bring Mendor's all-in-one blood glucose monitoring system to nine European markets

Mendor, the Finnish diabetes technology company, is proud to announce its partnership with A. Menarini Diagnostics S.r.l, one of Europe's leading diagnostics companies in the field of diabetes.

28 May 2013

Children with Type 2 diabetes are at high risk to develop heart, kidney and eye problems

The news about youth and diabetes keeps getting worse. The latest data from the national TODAY diabetes study shows that children who develop Type 2 diabetes are at high risk to develop heart, kidney and eye problems faster and at a higher rate than people who acquire Type 2 diabetes as adults.

26 May 2013

New evidence shows intensive insulin therapy does not provide substantial benefits

High blood glucose is associated with poor outcomes in hospitalized patients, and use of intensive insulin therapy (IIT) to control hyperglycemia is a common practice in hospitals. But the recent evidence does not show a consistent benefit and even shows harms associated with the use of IIT, according to the American College of Physicians' (ACP) Clinical Guidelines Committee in a new evidence-based paper published today online in the American Journal of Medical Quality.

24 May 2013

Potential new treatment approaches for liver diseases

By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.

24 May 2013

Highlights: Geography's role in elective surgeries in Calif.; Conn. Democrats eye shifting $400M in Medicaid money; HHS says Cedars-Sinai has $2.2M in billing errors

Geography plays a role in whether patients in California have elective operations such as joint replacement, weight loss surgery and gallbladder removal, according to a new study. The California HealthCare Foundation study showed wide variations in patient surgeries across the state (Gorman, 5/22).

24 May 2013

Lifestyle behaviors can lower risk of kidney failure in people with CKD

Lifestyle behaviors like working out and improving nutrition can lower the risk of kidney failure in people with chronic kidney disease, according to new research from the University of Alabama at Birmingham.

24 May 2013

Cinnamon compounds show some promise in the effort to fight Alzheimer's disease

Cinnamon: Can the red-brown spice with the unmistakable fragrance and variety of uses offer an important benefit? The common baking spice might hold the key to delaying the onset of -- or warding off -- the effects of Alzheimer's disease.

24 May 2013

New report says schools should engage pupils in vigorous or moderate physical activity daily

A new report from the Institute of Medicine says schools should be responsible for helping pupils engage in at least 60 minutes of vigorous or moderate intensity activity during each school day.

24 May 2013

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.

24 May 2013

Most residents dissatisfied with quality of substance-abuse training, survey finds

A 2012 survey of internal medicine residents at Massachusetts General Hospital (MGH) - one of the nation's leading teaching hospitals - found that more than half rated the training they had received in addiction and other substance use disorders as fair or poor.

24 May 2013

Researchers develop new guidelines to govern amount of blood ordered for surgical patients

Johns Hopkins researchers have developed new guidelines - the first in more than 35 years - to govern the amount of blood ordered for surgical patients.

23 May 2013

Endocrinology News and Research

Latest Endocrinology News and Research

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

Adult stem cells combined with new drug could hold key to curing type 1 diabetes

First Edition: May 29, 2013

Scientists discover new function of an enzyme that disposes of superfluous proteins

Offspring of long-lived parents less prone to cancer, study reveals

Harmless genetic variations may team up to increase risk of schizophrenia, find researchers

New Smartphone app helps maintain accurate records to manage diabetes

Synthetic compound derived from sea anemone toxin shows potential to treat obesity

Omthera to be acquired by AstraZeneca

New deal to bring Mendor's all-in-one blood glucose monitoring system to nine European markets

Children with Type 2 diabetes are at high risk to develop heart, kidney and eye problems

New evidence shows intensive insulin therapy does not provide substantial benefits

Potential new treatment approaches for liver diseases

Highlights: Geography's role in elective surgeries in Calif.; Conn. Democrats eye shifting $400M in Medicaid money; HHS says Cedars-Sinai has $2.2M in billing errors

Lifestyle behaviors can lower risk of kidney failure in people with CKD

Cinnamon compounds show some promise in the effort to fight Alzheimer's disease

New report says schools should engage pupils in vigorous or moderate physical activity daily

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Most residents dissatisfied with quality of substance-abuse training, survey finds

Researchers develop new guidelines to govern amount of blood ordered for surgical patients

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Endocrinology News and Research

Latest Endocrinology News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in